Brachial-ankle pulse wave velocity and microalbuminuria

Hypertension Research

Volumn 29, Issue 7, 2006, Pages 469-470

  Nakamura, Yoshio ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Arterial stiffness; Cardiovascular mortality; Endothelial dysfunction

Indexed keywords

ALBUMIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ARTERY COMPLIANCE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEGRADATION; DIABETES MELLITUS; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENDOTHELIUM LESION; HUMAN; HYPERTENSION; KIDNEY DISEASE; METABOLIC SYNDROME X; MICROALBUMINURIA; MORTALITY; NOTE; PODOCYTE; PREDICTION; PULSE WAVE; SENSITIVITY AND SPECIFICITY;

ALBUMINURIA; ANKLE; BIOLOGICAL MARKERS; BRACHIAL ARTERY; HUMANS; PROGNOSIS; REGIONAL BLOOD FLOW; RISK FACTORS;

EID: 33748556512     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.469     Document Type: Note

References (18)

1. Cohn JN: Introduction to surrogate markers. Circulation 2004; 109 (25 Suppl 1): IV20-IV21.
2. Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA: Surrogate markers for cardiovascular disease: functional markers. Circulation 2004; 109 (25 Suppl 1): IV31-IV46.
3. Oliver JJ, Webb DJ: Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003; 23: 554-566.
4. Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
5. Naka KK, Tweddel AC, Doshi SN, Goodfellow J, Henderson AH: Flow-mediated changes in pulse wave velocity: a new clinical measure of enclothelial function. Eur Heart J 2006; 27: 302-309.
6. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K: Arterial hypertension, Microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898-903.
7. Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
8. Hillege HL, Fidler V, Diercks GF, et al: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
9. Makino H, Nakamura Y, Wada J: Remission and regression of diabetic nephropathy. Hypertens Res 2003; 26: 515-519.
10. Arnlov J, Evans JC, Meigs JB, et al: Low-grade albuminuria and incidence of cardiovascular disease events in non-hypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969-975.
11. Haraldsson B, Sorensson J: Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci 2004; 19: 7-10.
12. Camici M: Renal glomerular permselectivity and vascular endothelium. Biorned Phannacother 2005; 59 (1-2): 30-37.
13. Bakris G: Proteinuria: a link to understanding changes in vascular compliance? Hypertension 2005; 46: 473-474.
14. Stehouwer CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM: Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction - the Hoorn Study. Kidney Int Suppl 2004; 92: S42-S44.
15. Pedrinelli R, Giampietro O, Carmassi F, et al: Micrcalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14-18.
16. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in noninsulin-dependent diabetes mellitus. Lancet 1992; 340: 319-323.
17. Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T: Microalburninuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res 2004; 27: 471-477.
18. Munakata M, Nunokawa T, Yoshinaga K, Toyota T, J-TOPP Sutdy Group: Brachial-ankle pulse wave velocity is an independent risk factor for microalburninuria in patients with essential hypertension - a Japanese Trial on the Prognostic Implication of Pulse Wave Velocity (J-TOPP). Hypertens Res 2006; 29: 515-521.